SCHEMBL13640478

SCHEMBL13640478

CC(=O)C(CS(=O)(=O)O)NC(=O)c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSV O60911 1/20 0.46
CTSL P07711 1/20 0.46
CTSS P25774 1/20 0.46
CTSK P43235 1/20 0.46
THRB P10828 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
FLT1 P17948 1/20 0.45
FLT4 P35916 1/20 0.45
KDR P35968 1/20 0.45
GAA P10253 1/20 0.44
UTS2R Q9UKP6 1/20 0.43
HTT P42858 1/20 0.43
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CCR1 P32246 2/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13583261 0.89 L3MBTL1 (0.48) CTSVCTSLCTSSCTSKTHRB
SCHEMBL2330381 0.89 L3MBTL1 (0.48) CTSVCTSLCTSSCTSKTHRB
SCHEMBL13583698 0.79 MEN1 (0.46) L3MBTL1MEN1KMT2A
SCHEMBL13583693 0.79 MEN1 (0.46) L3MBTL1MEN1KMT2A
SCHEMBL13583458 0.78 PYGL (0.46) CTSVCTSLCTSSCTSKL3MBTL1
SCHEMBL2327347 0.77 ITGB1 (0.41) L3MBTL1HPGDCYP2C19MEN1KMT2A
SCHEMBL13640476 0.77 NPC1 (0.52) CTSSCTSKL3MBTL1GAAUTS2R
SCHEMBL2327355 0.77 ITGB1 (0.41) L3MBTL1HPGDCYP2C19MEN1KMT2A
SCHEMBL13640417 0.77 SMN1; SMN2 (0.53) CTSVCTSLCTSSCTSKL3MBTL1
SCHEMBL10657352 0.76 L3MBTL1 (0.52) CTSVCTSLCTSSCTSKTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170119638-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR POLA CHEMICAL INDUSTRIES, INC. (JP) 2017-05-04 US disclosed
US-9066914-B2 Prophylactic or ameliorating agent for pigmentation POLA CHEMICAL INDUSTRIES INC. (JP) 2015-06-30 US disclosed
US-20120282203-A1 PROPHYLACTIC OR AMELIORATING AGENT FOR PIGMENTATION POLA CHEMICAL INDUSTRIES INC. (JP) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170119638-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR MC1R, TYR, NAMPT CTSV 4864/4885CTSL 4645/4885CTSS 4702/4885
US-20120282203-A1 PROPHYLACTIC OR AMELIORATING AGENT FOR PIGMENTATION TYR, MC1R, NQO1 CTSV 4437/4885CTSL 4466/4885CTSS 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.